2023
DOI: 10.1111/ans.18357
|View full text |Cite
|
Sign up to set email alerts
|

Early onset colorectal cancer in Canterbury, New Zealand

Abstract: BackgroundThe overall incidence of colorectal cancer is decreasing in much of the world, yet the incidence in those under 50 years of age is increasing (early onset colorectal cancer (EOCRC)). The reasons for this are unclear. This study was undertaken to describe the clinical, pathological and familial characteristics of patients with EOCRC and their oncological outcomes and compare this with previously published data on late onset colorectal cancer (LOCRC).MethodsA retrospective review of all patients diagno… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 54 publications
0
2
0
Order By: Relevance
“…The age‐standardized incidence of colon cancer has increased in Sweden since 1970 while that of rectal cancer has been relatively stable [1, 2]. In both men and women <50 years in Sweden the incidence of colorectal cancer (CRC) is increasing [3, 4] in accordance with reports from other western countries [5–7].…”
Section: Introductionmentioning
confidence: 94%
“…The age‐standardized incidence of colon cancer has increased in Sweden since 1970 while that of rectal cancer has been relatively stable [1, 2]. In both men and women <50 years in Sweden the incidence of colorectal cancer (CRC) is increasing [3, 4] in accordance with reports from other western countries [5–7].…”
Section: Introductionmentioning
confidence: 94%
“…The clinical characteristics of EOCRC can differ from late-onset colorectal cancer (LOCRC, diagnosed over 50 years of age), with EOCRC more likely to be left sided (sigmoid and rectum), have higher rates of mucinous or signet ring histology, be poorly differentiated, and present with advanced (stage 3 or 4) disease [5,6]. Despite these differences, a recent meta-analysis found no overall difference in cancer specific survival between early-onset and late-onset disease [7].…”
Section: Introductionmentioning
confidence: 99%